189 Epizód

  1. Precision Medicine for T-Cell Lymphomas: Expert Answers to Your Questions

    Közzétéve: 2022. 01. 31.

  2. Multidisciplinary Overview of EGFR-Mutated NSCLC: An Expert Panel Discussion From Biomarker Testing to Managing Progressive Disease

    Közzétéve: 2022. 01. 26.

  3. Experts Answer Questions on Current and Emerging Options for Hemophilia A Management

    Közzétéve: 2022. 01. 14.

  4. Induction and Maintenance Therapy for Fit Patients With AML Without Targetable Mutations

    Közzétéve: 2022. 01. 10.

  5. Strategies for Secondary AML and Emerging Therapies for AML

    Közzétéve: 2022. 01. 10.

  6. Targeted Treatment Options for Patients With AML and FLT3 or IDH1/2 Mutations

    Közzétéve: 2022. 01. 10.

  7. An Overview of AML and Treatment Strategies for Patients Unfit for Intensive Therapy

    Közzétéve: 2022. 01. 10.

  8. Managing Higher-Risk and Relapsed/Refractory Myelodysplastic Syndromes: Nursing Implications

    Közzétéve: 2021. 12. 22.

  9. Managing Lower-Risk Myelodysplastic Syndrome: Nursing Implications

    Közzétéve: 2021. 12. 22.

  10. Key Factors Influencing Later-Line Treatment Selection for Patients With Metastatic Colorectal Cancer

    Közzétéve: 2021. 12. 17.

  11. The Evolving Role of TKIs in First-line Treatment of Advanced HCC

    Közzétéve: 2021. 12. 14.

  12. Expert Insight on Important Clinical Trial Data From ESGO 2021 Informing Treatment for Ovarian Cancer and Endometrial Cancers

    Közzétéve: 2021. 11. 23.

  13. Experts Answer FAQs on Immunotherapy for Non-Small-Cell Lung Cancer

    Közzétéve: 2021. 11. 23.

  14. Overcoming Acquired Resistance With Second-Generation TRK Inhibitors

    Közzétéve: 2021. 11. 09.

  15. Role of TKIs in Nonadipocytic Soft Tissue Sarcoma and Advanced Osteosarcoma

    Közzétéve: 2021. 11. 02.

  16. PARP Inhibitors in Pancreatic Cancer: Experts Discuss Importance of Testing for Biomarkers Along With Current Treatment Landscape

    Közzétéve: 2021. 10. 26.

  17. Optimal Dosing Strategies With Regorafenib and TAS-102 for Patients With Metastatic Colorectal Cancer

    Közzétéve: 2021. 10. 21.

  18. First-Generation TRK Inhibitors: Clinical Evidence and Indications

    Közzétéve: 2021. 10. 15.

  19. PARP Inhibitors in Ovarian Cancer: Experts Discuss Patient Cases and the Current Paradigm

    Közzétéve: 2021. 10. 14.

  20. Counseling Patients and Caregivers on Prophylaxis Therapy for Severe Hemophilia A

    Közzétéve: 2021. 10. 08.

5 / 10

Updates on new data and best practices in the care of patients with cancer across a wide variety of solid tumors and hematologic malignancies from Clinical Care Options. Gain practical clinical insights and strategies and earn CME/CE credit for selected episodes.

Visit the podcast's native language site